Journal rankings · indicator year 2008
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2008
Cellular and Molecular Neuroscience journal rankings 2008
31 ranked journals · Subfield in Neuroscience
Cellular and Molecular Neuroscience has 31 ranked journals in 2008. The median OJR rose 0.05 on 2007 to 0.94, below the world average of 1.00; Q1 starts at OJR 1.35. The top three are Brain Research Reviews, NeuroRx, and Neuropsychopharmacology.
Ranks and citation indicators: 2008. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2005–2007, the window the 2008 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Neuroscience (8)
31 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2007. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2005–2007, the window the 2008 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2005–2007 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2008. | Compare |
|---|---|---|---|---|---|---|---|
1Brain Research ReviewsElsevier BV · Netherlands | 2.74Q1 | 6.91 0.11 down from 2007 | 334 | 33% | — | ||
2NeuroRxSpringer Nature · United States | 2.53Q1 | 4.81 0.70 down from 2007 | 101 | — | — | ||
3NeuropsychopharmacologySpringer Nature · United States | 2.52Q1 | 6.69 0.64 up from 2007 | 948 | 55% | $5,290 | ||
4CNS Drug ReviewsWiley · United States | 2.06Q1 | 5.94 1.85 up from 2007 | 69 | — | — | ||
5PsychopharmacologySpringer Science+Business Media · Germany | 1.68Q1 | 4.81 0.22 up from 2007 | 1,202 | 45% | $4,390 | ||
6Addiction BiologyOAWiley · United Kingdom | 1.55Q1 | 4.88 1.60 up from 2007 | 110 | 39% | $3,150 | ||
7The Journal of Comparative NeurologyWiley · United States | 1.46Q1 | 4.01 0.46 down from 2007 | 1,156 | 48% | $5,450 | ||
8NeuropharmacologyElsevier BV · Netherlands | 1.35Q1 | 3.95 0.30 up from 2007 | 814 | 37% | $4,300 | ||
9Journal of NeurobiologyWiley · United States | 1.27Q2 | 3.85 0.23 up from 2007 | 222 | — | — | ||
10Journal of Neuroscience ResearchWiley · United States | 1.22Q2 | 3.28 0.25 down from 2007 | 1,168 | 25% | $4,840 | ||
11Developmental NeurobiologyWiley · United States | 1.16Q2 | 2.76 0.36 up from 2007 | 180 | 39% | $4,550 | ||
12Pharmacology Biochemistry and BehaviorElsevier BV · United States | 1.13Q2 | 3.04 0.19 up from 2007 | 763 | 41% | $3,650 | ||
13The CerebellumSpringer Science+Business Media · United Kingdom | 1.08Q2 | 3.28 0.79 up from 2007 | 145 | 20% | $4,790 | ||
14Behavioural PharmacologyLippincott Williams & Wilkins · United Kingdom | 1.07Q2 | 2.82 0.24 up from 2007 | 259 | 41% | — | ||
15AlcoholElsevier BV · United Kingdom | 1.02Q2 | 2.45 0.22 up from 2007 | 200 | 18% | $3,720 | ||
16Journal of Comparative Physiology ASpringer Science+Business Media · Germany | 0.94Q2 | 2.14 0.30 up from 2007 | 382 | 21% | $3,990 | ||
17SynapseWiley · United States | 0.92Q3 | 2.96 0.15 up from 2007 | 379 | 33% | $3,570 | ||
18Molecular Brain ResearchElsevier BV · Netherlands | 0.89Q3 | —no 2007 value | 269 | — | — | ||
19Invertebrate NeuroscienceSpringer Science+Business Media · Germany | 0.87Q3 | 2.04 0.19 up from 2007 | 63 | 37% | $3,860 | ||
20Developmental Brain ResearchElsevier BV · Netherlands | 0.84Q3 | —no 2007 value | 158 | — | — | ||
21Journal of NeurocytologySpringer Nature · Netherlands | 0.82Q3 | 1.90 0.07 down from 2007 | 51 | 58% | — | ||
22Regulatory PeptidesElsevier BV · Netherlands | 0.81Q3 | 2.15 0.03 down from 2007 | 447 | 12% | — | ||
23Brain Research ProtocolsElsevier BV · Netherlands | 0.80Q3 | —no 2007 value | 49 | — | — | ||
24NeuropeptidesElsevier BV · United Kingdom | 0.73Q3 | 1.87 0.20 down from 2007 | 214 | 16% | $3,530 | ||
25Journal of Neurosurgery PediatricsUnited States | 0.72Q4 | 1.56 0.11 up from 2007 | 432 | 5% | — | ||
26Critical Reviews in NeurobiologyBegell House · United States | 0.72Q4 | 1.20 0.27 up from 2007 | 34 | 0% | — | ||
27Neuron Glia BiologyCambridge University Press · United Kingdom | 0.71Q4 | 1.74 0.08 up from 2007 | 79 | 48% | — | ||
28Child s Nervous SystemSpringer Science+Business Media · Germany | 0.68Q4 | 1.55 0.32 up from 2007 | 677 | 9% | $4,790 | ||
29min - Minimally Invasive NeurosurgeryThieme Medical Publishers (Germany) · Germany | 0.49Q4 | 0.92 0.17 down from 2007 | 228 | 1% | — | ||
30Journal of NeurogeneticsTaylor & Francis · Switzerland | 0.29Q4 | 0.81 0.27 up from 2007 | 47 | 24% | — | ||
31Cerebrospinal Fluid ResearchOABritish Motor Corporation · United Kingdom | 0.11Q4 | 0.27 0.14 down from 2007 | 207 | 100% | $1,680 |
Subfields of Neuroscience, with Cellular and Molecular Neuroscience highlighted.
- Cognitive Neuroscience185
- Cellular and Molecular Neuroscience31
- Neurology12
- Sensory Systems5
- Behavioral Neuroscience3
- Endocrine and Autonomic Systems3
- Biological Psychiatry2
- Developmental Neuroscience1
Journals
Citations made in 2008. Corpus-wide, 71.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
9 additional Cellular and Molecular Neuroscience journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2005–2007, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2008. Publication window: 2005–2007. How these summaries are calculated
- Ranked journals
- 31
- Window papers (baseline)
- 38,951 +2.2% from indicator year 2005
- Median OJR
- 0.94 +4.8% from indicator year 2005
- Rising journals (2025)
- 1
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2005–2007 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 27 | 27 | 26 | 27 | 27 | 32 | 32 | 32 | 31 | 27 | 30 | 32 | 33 | 32 | 30 | 30 | 32 | 32 | 29 | 32 | 33 | 33 | 33 | 32 | 31 | 30 | |
| Window papers (baseline) | 37,773 | 38,664 | 38,213 | 37,940 | 37,414 | 38,123 | 38,289 | 38,810 | 38,951 | 41,086 | 41,577 | 41,975 | 41,244 | 41,433 | 42,264 | 42,615 | 42,554 | 41,749 | 40,554 | 39,909 | 39,604 | 39,824 | 40,023 | 39,750 | 39,038 | 38,750 | |
| Median OJR | 0.73 | 0.74 | 0.83 | 0.790 | 0.86 | 0.894 | 0.91 | 0.885 | 0.94 | 1.16 | 1.18 | 1.12 | 1.07 | 1.147 | 1.14 | 1.153 | 1.13 | 1.149 | 1.146 | 1.04 | 1.004 | 0.997 | 0.93 | 0.88 | 0.90 | 0.791 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.